The Phase 3 "BASIS" trial data, showcased at the American Society of Hematology (ASH) annual meeting, showed significant promise. For patients with inhibitors—a subgroup historically difficult to ...

3SBio, a China partner of U.S. drug giant Pfizer, has reached agreements to raise approximately $400 million in a share ...

U.S. president boasted that drug prices were falling ‘700%’, a mathematical impossibility, as a result of his executive ...

He’s the de facto head of a Saudi regime which, according to the non-profit organisation Freedom House, “restricts almost all political rights and civil liberties” for its citizens, using “pervasive ...

President Trump and Elon Musk are back on good terms after their feud, which the world witnessed six months ago. The billionaire was seen attending the lavish banquet organised by the US President in ...

President Donald Trump calls for investigation into officials who pushed climate change at Saudi investment forum, ...

Here are some of the notable guests invited to President Trump’s dinner for Crown Prince Mohammed bin Salman of Saudi Arabia.

Pfizer's CEO certainly thinks so. In a TV interview, Bourla said: "Pfizer, when it plays, plays big. And we will -- as we did in COVID, as we did with Lipitor, as we did with ... Viagra, as we did ...

Pfizer (PFE) CEO Albert Bourla said he's learned to work with some unlikely allies — even those who once questioned the very foundation of his business. "Clearly, that was not going to be my choice ...

Pfizer Chief Executive Albert Bourla had long searched for an obesity drug to make up for dwindling sales of the pharma company’s aging blockbusters. Late Friday, after a dramatic bidding war, he ...

Novo Nordisk is raising the stakes in its push to outbid rival Pfizer and acquire the development-stage drugmaker Metsera. Novo is now offering to pay as much as $10 billion for the company, Metsera ...